MedTrace Logo

Program of Health Behaviour Against to Cancer (PHeBAC)

NCT06371469 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-05-24

No results posted yet for this study

Summary

The European Code Against Cancer contains 12 recommendations to reduce the risk of cancer. It is estimated that about half of all cancers could be prevented if all recommendations are followed.

The aim of this study was to evaluate the effectiveness of the Program of Health Behaviour Against Cancer (PHeBAC) applied to mothers of children with intellectual disabilities in increasing the participation of mothers and their children with intellectual disabilities in cancer screenings and their health behaviors against cancer. The goal is to improve the preventive health behaviors of children with intellectual disabilities and their mothers against cancer and to increase the rate of participation in cancer screenings. Specific targets are; not smoking and not being exposed to smoking, increasing physical activity, healthy nutrition, limiting alcohol consumption, protection from sunlight, HPV vaccination and increasing participation in breast, cervical and colorectal cancer screenings.

Conditions

  • Cancer Prevention
  • Health Behavior
  • Disability, Intellectual
  • Parents
  • Cancer Screening
  • Experimental Study Designs
  • Mothers
  • Disabilities Mental

Interventions

BEHAVIORAL

PHeBAC

Multi-interventions to health behaviour against cancer in mothers of Intellectual Disabled Children

BEHAVIORAL

Control Group

Providing brochures from the Ministry of Health, answering questions and providing the researcher's phone number

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Principal Investigators

  • Habibe OZCELIK, PhD · Akdeniz University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-20
Primary Completion
2024-07-20
Completion
2024-08-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06371469 on ClinicalTrials.gov